|
Volumn 72, Issue 12, 2013, Pages 2051-2053
|
Fetal outcomes after rituximab exposure in women with autoimmune vasculitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CD20 ANTIGEN;
CYCLOPHOSPHAMIDE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
RITUXIMAB;
ADOLESCENT;
ADULT;
AGED;
B LYMPHOCYTE;
BECKWITH WIEDEMANN SYNDROME;
FEMALE;
FETUS;
FETUS DEATH;
FETUS OUTCOME;
HUMAN;
HUMAN TISSUE;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MICROSCOPIC POLYANGIITIS;
POLYARTERITIS NODOSA;
PREGNANCY;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SPONTANEOUS ABORTION;
VASCULITIS;
WEGENER GRANULOMATOSIS;
AUTOIMMUNITY;
B CELLS;
SYSTEMIC VASCULITIS;
ADOLESCENT;
ADULT;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
AUTOIMMUNE DISEASES;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFANT, NEWBORN;
MATERNAL-FETAL EXCHANGE;
PREGNANCY;
PREGNANCY OUTCOME;
PRENATAL EXPOSURE DELAYED EFFECTS;
RETROSPECTIVE STUDIES;
VASCULITIS;
YOUNG ADULT;
|
EID: 84887484168
PISSN: 00034967
EISSN: 14682060
Source Type: Journal
DOI: 10.1136/annrheumdis-2013-203833 Document Type: Letter |
Times cited : (29)
|
References (6)
|